SCHEMBL1901468

SCHEMBL1901468

CCOc1ccc(C(=O)c2ccc(Nc3ccc(Br)cc3C)cc2Cl)c(C)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.57
MAPK12 P53778 10/20 0.57
MAPK11 Q15759 10/20 0.57
MAPK14 Q16539 10/20 0.57
MAPT P10636 6/20 0.46
GAA P10253 4/20 0.46
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
HTT P42858 1/20 0.44
THRB P10828 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 2/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SLC2A1 P11166 1/20 0.41
TP53 P04637 1/20 0.40
PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6395613 0.91 MAPK14 (0.70) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199402 0.90 MAPK14 (0.55) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2200586 0.89 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2198438 0.89 MAPK13 (0.54) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL1903141 0.89 MAPK13 (0.60) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL7196956 0.88 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL1906378 0.88 MAPT (0.51) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6821134 0.87 MAPK13 (0.61) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6906823 0.86 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL1905203 0.86 MAPT (0.44) MAPK13MAPK12MAPK11MAPK14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4684515-B2 2011-05-18 JP claimed
EP-1237845-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2007-05-23 EP claimed
US-6541670-B2 Antiinflammatory agents LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-01 US claimed
US-20030013770-A1 Aminobenzophenones as inhibitors of il 1b and tnf LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-01-16 US claimed
EP-1237845-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-09-11 EP claimed
WO-2001042189-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-06-14 WO claimed
EP-1237845-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2007-05-23 EP disclosed
US-6541670-B2 Antiinflammatory agents LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-01 US disclosed
US-20030013770-A1 Aminobenzophenones as inhibitors of il 1b and tnf LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-01-16 US disclosed
EP-1237845-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-09-11 EP disclosed
WO-2001042189-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013770-A1 Aminobenzophenones as inhibitors of il 1b and tnf IL1B, IL1A, IL6 MAPK13 2221/4885MAPK12 1892/4885MAPK11 1835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.